TrialJAMA oncology2022

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.

Miguel Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.